Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment

Br J Dermatol. 2024 Apr 17;190(5):e58. doi: 10.1093/bjd/ljae124.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cell Proliferation
  • Humans
  • Melanoma* / pathology
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics

Substances

  • Proto-Oncogene Proteins B-raf
  • BRAF protein, human